MedTrace Logo

ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

NCT06790355 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2527

Last updated 2025-01-24

No results posted yet for this study

Summary

This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.

Conditions

Interventions

DEVICE

multi-cancer early detection

Blood collection for multi-cancer early detection（MCED）, followed by clinical diagnosis based on the results of MCED and standard-of-care screening

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER

  • Shanghai Weihe Medical Laboratory Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xianjun Yu · Fudan University

  • Xiaohui Wu · Shanghai Weihe Medical Laboratory Co., Ltd.

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06790355 on ClinicalTrials.gov